Table 3.

Clinicopathological characteristics of NAGK, ACTR1A, B3GNT3, EXOC1, FXYD3, SIGIRR in pancreatic cancer patients by UALCAN

Parameters		p value
		NAGK	ACTR1A	B3GNT3	EXOC1	FXYD3	SIGIRR
Age	21-40	0.007	0.950	0.321	0.384	0.356	0.803
	41-60	1.54E-05	0.864	1.87E-12	0.737	2.38E-13	0.655
	61-80	2.71E-06	0.602	8.78E-12	0.844	<1E-12	0.722
	81-100	0.003	0.387	3.94E-05	0.697	7.51E-05	0.426
Gender	Female	2.14E-05	0.824	5.01E-11	0.958	<1E-12	0.552
	Male	2.31E-06	0.665	1.09E-13	0.941	1.62E-12	0.783
Cancer stage	1	1.18E-04	0.520	0.073	0.650	0.033	0.675
	2	3.98E-06	0.634	7.64E-11	0.995	<1E-12	0.723
	3	0.079	0.776	0.113	0.316	0.061	0.428
	4	0.006	0.942	0.063	0.499	0.038	0.320
Tumor grade	1	0.862	0.323	0.101	0.979	0.204	0.209
	2	0.937	0.640	0.027	0.815	0.889	0.107
	3	0.939	0.674	0.019	0.317	0.034	0.108
	4	1	1	1	1	1	1
Nodal Metastasis status	N0	1.48E-06	0.914	6.30E-12	0.805	2.78E-11	0.998
	N1	1.88E-05	0.656	1.27E-11	0.970	1.62E-12	0.564
Alcohol history	Yes	1.42E-04	0.634	4.32E-09	0.459	2.32E-06	0.915
	No	2.01E-04	0.361	1.11E-06	0.962	5.85E-07	0.924
Diabetes history	Yes	8.40E-04	0.717	2.65E-09	0.607	1.09E-07	0.827
	No	3.09E-07	0.749	1.20E-11	0.920	<1E-12	0.789
Chronic pancreatitis status	Yes	1.40E-04	0.496	3.99E-05	0.677	1.01E-04	0.425
	No	1.59E-05	0.682	4.42E-11	0.781	1.62E-12	0.673